獣医用医薬品の世界市場レポート 2025年

獣医用医薬品の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で505億9,000万米ドルに成長します。予測期間における成長は、ペット飼育の増加、人口増加、可処分所得の増加、都市化の進展、ペット保険の普及、政府支援の拡大などが市場を牽引するものと考えられます。予測期間における主な動向としては、動物を治療するための幹細胞療法への注目、抗生物質耐性に対処するための獣医用医薬品へのナノテクノロジーの応用への注目、チュアブル錠剤の開発、COVID-19の影響を軽減するための遠隔医療プラットフォームの利用への注目、高度なワクチンの開発、スーパーコンボ寄生虫駆除薬への注目、サブユニットおよびウイルス様粒子（VLP）ベースのワクチンの利用、戦略的パートナーシップおよび共同研究への注目などが挙げられます。

獣医用医薬品市場は、動物における疾病の有病率の顕著な増加によって牽引されています。家畜とコンパニオンアニマルの両方における疾病発生率の急増は、効果的な治療のための医薬品を必要とします。重要な例として、Banfield State of Pet Health Reportによると、犬の糖尿病症例が79.7%増加し、1万頭あたり13.1症例から23.6症例になったと報告されています。このような疾病の増加は、獣医用医薬品に対する需要の高まりを裏付けています。

ペット飼育の動向は、獣医用医薬品市場の成長を当面促進すると予想されます。ペットの所有には、飼われている動物の幸福に対する個人や家庭の法的・倫理的責任が含まれます。ペットの飼い主が増加するにつれ、様々な動物種、品種、健康状態に対応する専門的な医薬品の需要も増加しています。2023年に米国ペット用品協会（American Pet Products Association Inc.）が発表した報告書によると、米国世帯の66％がペットを飼っており、2022年には62％、犬は44.5％、猫は29％の世帯が飼っていることが明らかになりました。このペット飼育の急増は、獣医用医薬品市場の主要促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の獣医用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の獣医用医薬品市場：成長率分析
• 世界の獣医用医薬品市場の実績：規模と成長, 2019-2024
• 世界の獣医用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界の獣医用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の獣医用医薬品市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 獣医用ワクチン
• 獣医用抗生物質
• 獣医用寄生虫駆除剤
• その他のタイプ
• 世界の獣医用医薬品市場：動物タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンパニオンアニマル
• 家畜
• 世界の獣医用医薬品市場：ワクチン別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• 弱毒化ワクチン
• 組み換えワクチン
• 世界の獣医用医薬品市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• その他の投与経路
• 世界の獣医用医薬品市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 獣医クリニック
• 薬局とドラッグストア
• 世界の獣医用医薬品市場、タイプ別サブセグメンテーション：獣医用ワクチン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• DNAワクチン
• サブユニットワクチン
• 世界の獣医用医薬品市場、タイプ別サブセグメンテーション：獣医用抗生物質、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシリン
• セファロスポリン
• テトラサイクリン
• フルオロキノロン
• マクロライド
• 世界の獣医用医薬品市場、タイプ別サブセグメンテーション：獣医用寄生虫駆除剤、実績と予測, 2019-2024, 2024-2029F, 2034F
• 内部寄生虫駆除剤
• 外部寄生虫駆除剤
• 内外部寄生虫駆除剤
• 抗原虫
• 世界の獣医用医薬品市場、タイプ別サブセグメンテーション：その他の獣医用医薬品、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗炎症薬
• 鎮痛剤
• ホルモン剤
• 抗真菌薬

第7章 地域別・国別分析

• 世界の獣医用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の獣医用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医用医薬品市場：競合情勢
• 獣医用医薬品市場：企業プロファイル
  • Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co., Inc Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International Gmb Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Virbac SA
• Dechra Pharmaceuticals PLC
• Vetoquinol S.A.
• Phibro Animal Health Corporation
• Kyoritsu Seiyaku Corporation
• Hebei Chengshengtang Animal Pharmaceutical
• Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
• Vvaan Lifesciences Private Limited
• Century Pharmaceuticals Limited
• Cargill India Pvt. Ltd.
• Jurox Pty Ltd
• Bayer
• Veteq
• Nimrod Veterinary Products Ltd.
• Bimeda

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 獣医用医薬品市場2029：新たな機会を提供する国
• 獣医用医薬品市場2029：新たな機会を提供するセグメント
• 獣医用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary pharmaceuticals constitute a category of pharmacologically active drugs employed to control, prevent, and treat diseases in animals. These drugs exhibit their effects upon administration to animals and undergo rapid breakdown into active ingredients, primarily facilitated by small intestine metabolism.

The primary types of veterinary pharmaceuticals encompass veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other varieties. Veterinary vaccines offer protection against one or more diseases, mitigating their severity or preventing them altogether. The routes of administration include oral and various other routes tailored to different animal types, including companion animals and livestock. The vaccines themselves are classified into categories such as inactivated vaccines, attenuated vaccines, recombinant vaccines, and others, and they are supplied by diverse end-users, including veterinary hospitals, veterinary clinics, pharmacies, and drug stores.

The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmaceuticals market size has grown strongly in recent years. It will grow from $35.36 billion in 2024 to $37.87 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increased pet population, the increased overall spending by individuals on pets, the growing penetration of e-commerce platforms promoting online pharmacies, the emerging markets growth, the increasing government initiatives and the increased disease prevalence.

The veterinary pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $50.59 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing pet ownership, the increasing population growth, the increasing disposable income, the increasing urbanization, the increasing penetration of pet insurance and the growing government support will drive the market. Major trends in the forecast period include focus on stem cell therapy to treat animals, focus on application of nanotechnology in veterinary medicines to tackle antibiotic resistance, development of chewable tablets, focus on use of telemedicine platforms to reduce the impact of COVID-19, development of advanced vaccines, focus on super-combo parasiticides, use of subunit and virus-like particle (VLP)-based vaccines and focus on strategic partnerships and collaborations.

The veterinary pharmaceuticals market is being driven by a notable increase in the prevalence rate of diseases among animals. The upsurge in disease incidence in both livestock and companion animals necessitates medicines for effective treatment. A significant example is the reported 79.7% increase in diabetes cases in dogs, from 13.1 cases per 10,000 to 23.6 cases, according to the Banfield State of Pet Health Report. This rise in disease prevalence underscores the heightened demand for veterinary pharmaceuticals.

The growing trend of pet ownership is anticipated to propel the growth of the veterinary pharmaceuticals market in the foreseeable future. Pet ownership involves the legal and ethical responsibility of individuals or households for the well-being of domesticated animals. As the number of pet owners increases, there is a corresponding rise in demand for specialized medications catering to various species, breeds, and health conditions. In 2023, a report from the American Pet Products Association Inc. revealed that 66% of US households owned pets, compared to 62% in 2022, with dogs being owned by 44.5% and cats by 29% of households in 2022. This surge in pet ownership is a key driver of the veterinary pharmaceuticals market.

Government agencies such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regulate the veterinary pharmaceuticals market. Notably, the EU agencies require 6 to 12 months for the approval of veterinary medicinal products, and all parts of the registration dossier must be submitted together. In contrast, the US-FDA accepts phased submissions and assesses each technical section for 6 months. Efficient planning, effective communication, and careful consideration of regulatory policies are crucial for manufacturers in navigating the approval process and minimizing costs and timelines.

The emergence of generic drugs for animal care is a notable trend in the veterinary pharmaceuticals market. The cost-effectiveness of generic drugs has led to increased adoption by pet owners, with the FDA approving 22 generic animal drugs for cats and dogs. A survey of 520 veterinarians revealed that around 80% are using generic drugs to save pet owners money. Despite the lower profit margins compared to branded drugs, veterinarians are favoring generic drugs for their economic benefits.

Major companies in the veterinary pharmaceuticals market are innovating by introducing new products such as molidustat oral suspensions to expand customer bases and increase revenue. Elanco Animal Health Incorporated, for example, launched Varenzin-CA1 (molidustat oral suspension), the first medication for managing non-regenerative anemia in cats with chronic kidney disease (CKD). This needle-free oral suspension allows at-home administration, receiving provisional approval from the FDA. The unique features of Varenzin-CA1 showcase a commitment to providing novel therapies and expanding treatment options for animals with specific conditions or illnesses lacking effective treatments.

Major companies operating in the veterinary pharmaceuticals market include Zoetis Inc, Merck & Co., Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd

North America was the largest region in the veterinary pharmaceuticals market in 2024. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals
• 2) By Type Of Animal: Livestock, Companion Animals
• 3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines
• 4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration
• 5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores
• Subsegments:
• 1) By Veterinary Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; DNA Vaccines; Subunit Vaccines
• 2) By Veterinary Antibiotics: Penicillins; Cephalosporins; Tetracyclines; Fluoroquinolones; Macrolides
• 3) By Veterinary Parasiticides: Endoparasiticides; Ectoparasiticides; Endectocides; Antiprotozoals
• 4) By Other Veterinary Pharmaceuticals: Anti-inflammatory Drugs; Analgesics; Hormonal Medications; Antifungals
• Companies Mentioned: Zoetis Inc; Merck & Co., Inc; Boehringer Ingelheim International Gmb; Elanco Animal Health Incorporated; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Pharmaceuticals Market Characteristics

3. Veterinary Pharmaceuticals Market Trends And Strategies

4. Veterinary Pharmaceuticals Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Veterinary Pharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Pharmaceuticals Market Growth Rate Analysis
• 5.4. Global Veterinary Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Pharmaceuticals Total Addressable Market (TAM)

6. Veterinary Pharmaceuticals Market Segmentation

• 6.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Vaccines
• Veterinary Antibiotics
• Veterinary Parasiticides
• Other Types
• 6.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animals
• Livestock Animals
• 6.3. Global Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Attenuated Vaccines
• Recombinant Vaccines
• 6.4. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Other Routes Of Administration
• 6.5. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies And Drug Stores
• 6.6. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Subunit Vaccines
• 6.7. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillins
• Cephalosporins
• Tetracyclines
• Fluoroquinolones
• Macrolides
• 6.8. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Parasiticides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoparasiticides
• Ectoparasiticides
• Endectocides
• Antiprotozoals
• 6.9. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Other Veterinary Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-inflammatory Drugs
• Analgesics
• Hormonal Medications
• Antifungals

7. Veterinary Pharmaceuticals Market Regional And Country Analysis

• 7.1. Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Pharmaceuticals Market

• 8.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Pharmaceuticals Market

• 9.1. China Veterinary Pharmaceuticals Market Overview
• 9.2. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Pharmaceuticals Market

• 10.1. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Pharmaceuticals Market

• 11.1. Japan Veterinary Pharmaceuticals Market Overview
• 11.2. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Pharmaceuticals Market

• 12.1. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Pharmaceuticals Market

• 13.1. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Pharmaceuticals Market

• 14.1. South Korea Veterinary Pharmaceuticals Market Overview
• 14.2. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Pharmaceuticals Market

• 15.1. Western Europe Veterinary Pharmaceuticals Market Overview
• 15.2. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Pharmaceuticals Market

• 16.1. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Pharmaceuticals Market

• 17.1. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Pharmaceuticals Market

• 18.1. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Pharmaceuticals Market

• 19.1. Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Pharmaceuticals Market

• 20.1. Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Pharmaceuticals Market

• 21.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
• 21.2. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Pharmaceuticals Market

• 22.1. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Pharmaceuticals Market

• 23.1. North America Veterinary Pharmaceuticals Market Overview
• 23.2. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Pharmaceuticals Market

• 24.1. USA Veterinary Pharmaceuticals Market Overview
• 24.2. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Pharmaceuticals Market

• 25.1. Canada Veterinary Pharmaceuticals Market Overview
• 25.2. Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Pharmaceuticals Market

• 26.1. South America Veterinary Pharmaceuticals Market Overview
• 26.2. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Pharmaceuticals Market

• 27.1. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Pharmaceuticals Market

• 28.1. Middle East Veterinary Pharmaceuticals Market Overview
• 28.2. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Pharmaceuticals Market

• 29.1. Africa Veterinary Pharmaceuticals Market Overview
• 29.2. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Pharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Pharmaceuticals Market Competitive Landscape
• 30.2. Veterinary Pharmaceuticals Market Company Profiles
  • 30.2.1. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co., Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim International Gmb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Pharmaceuticals Market Other Major And Innovative Companies

• 31.1. Virbac SA
• 31.2. Dechra Pharmaceuticals PLC
• 31.3. Vetoquinol S.A.
• 31.4. Phibro Animal Health Corporation
• 31.5. Kyoritsu Seiyaku Corporation
• 31.6. Hebei Chengshengtang Animal Pharmaceutical
• 31.7. Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
• 31.8. Vvaan Lifesciences Private Limited
• 31.9. Century Pharmaceuticals Limited
• 31.10. Cargill India Pvt. Ltd.
• 31.11. Jurox Pty Ltd
• 31.12. Bayer
• 31.13. Veteq
• 31.14. Nimrod Veterinary Products Ltd.
• 31.15. Bimeda

32. Global Veterinary Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

34. Recent Developments In The Veterinary Pharmaceuticals Market

35. Veterinary Pharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Pharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer